Table 2.
Presence of Brn-3a and E6 mRNA in the cervix of women in Recife-Brazil with different forms of cervical precancer lesions and a cervicitis control group.
| Women from Brazil | ||||
|
| ||||
| Pathology | Brn-3a mRNA present | HPV E6 mRNA present | ||
| (no. of cases) | no. (%) | no. (%) | ||
|
| ||||
| Cervicitis (32 ) | 18 (56.3) | 15 (46.8) | ||
| SCC precancer (32) | 32 (100) | 30 (93.7) | ||
| AC precancer (17) | 17 (100) | 15 (88.2) | ||
| SSCC (2) | 2 (100) | 2 (100) (%) | ||
|
| ||||
| Women from England | ||||
|
| ||||
| Pathology | Brn-3a mRNA present | HPV E6 mRNA present | ||
| (no. of cases) | no. (%) | no. (%) | ||
|
| ||||
| Cervicitis (32) | 15 (46.8) | 12 (37.5) | ||
| SCC precancer (17) | 16 (94.1) | 13 (76.4) | ||
| AC precancer (4) | 4 (100) | 4 (100) | ||
| SSCC (0) | — | — | ||
|
| ||||
| Total no of pathological cases in Study | ||||
|
| ||||
| Total pathological cases in | Brn-3a mRNA present | HPV E6 mRNA present | ||
| study (no.) | no. (%) | no. (%) | ||
|
| ||||
| Cervicitis (64) | 33 (51.5) | 27 (42.2) | ||
| SCC precancer (49) | 48 (97.9) | 33 (67.3) | ||
| AC precancer (21) | 21 (100) | 19 (90.4) | ||
| SSCC (2) | 2 (100) | 2 (100) | ||